NCT06525766
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
Clinical trial condition
Estrogen-receptor-positive Breast Cancer
Explore clinical trials studying Estrogen-receptor-positive Breast Cancer. Study availability and eligibility vary by location and protocol.
10 public trials
6 recruiting studies
Estrogen-receptor-positive Breast Cancer trial results
NCT07340541
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Mayo Clinic Rochester, Minnesota, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
- Yale Cancer Center Clinical Trials Office New Haven, Connecticut, United States
NCT06062498
- Conditions
- Advanced Breast Cancerv, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Rush University Medical Center Chicago, Illinois, United States
- University of Chicago Chicago, Illinois, United States
Recruiting
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
NCT07222215
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06867484
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Lynn Cancer Institute at Baptist Health, Inc. Boca Raton, Florida, United States
- Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
NCT06150898
- Conditions
- Body Weight, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Institut Jules Bordet Brussels, Brussels Capital, Belgium
Not yet recruiting
Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
NCT07499999
- Conditions
- Adenocarcinoma, Ataxia Telangiectasia Mutated Gene Mutation, Atypical Lobular Hyperplasia, +16 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
NCT05607004
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen-receptor-positive Breast Cancer, +6 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- University of Arizona Tucson, Arizona, United States
- California Research Institute Los Angeles, California, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
Completed
The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity
NCT06343987
- Conditions
- Adiposity, Behavior, Body Weight, +16 more
- Locations
-
- Department of Oncology, Aarhus University Hospital Aarhus N, Central Jutland, Denmark
NCT06006910
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States